THIODARON
The image of the packaging corresponds to the packaging currently registered with the regulatory authorities of Ukraine.
In case of any discrepancies, please contact us at tel. +380 44 490 75 22
Tablets №30.
The image of the packaging corresponds to the packaging currently registered with the regulatory authorities of Ukraine.
In case of any discrepancies, please contact us at tel. +380 44 490 75 22
-
Prevention of recurrences of life-threatening ventricular tachycardia or ventricular fibrillation, symptomatic ventricular tachycardia; supraventricular tachycardia; heat rhythm disorders in case of resistance to or contraindication of other treatments; heart rhythm disorders attributable to WPW syndrome.Treatment of supraventricular tachycardia to slow down the heart rate or to restore the sinus rhythm in cases of atrial fibrillation and atrial flutter. The medication is recommended for patients with ischemic heart disease and/or impaired left ventricular function for managing documented supraventricular tachycardia to control the heart rate in case of atrial fibrillation and atrial flutter.
-
1 tablet contains 0.2 g of amiodarone hydrochloride, 0.1 g of thiotriazoline.
